Serono/OSI's Novantrone Adds Boxed Warning On Leukemia And Cardiotoxicity
This article was originally published in The Pink Sheet Daily
Executive Summary
Serono and OSI added the warnings following cardiotoxicty reports from post-marketing surveillance and secondary acute myelogenous leukemia reports from peer-reviewed literature, spontaneous reports and a prospective observational study, a "Dear Doctor" letter states.